Harbor Capital Advisors’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-764
Closed -$16K – 1398
2025
Q4
$16K Sell
764
-13
-2% -$266 ﹤0.01% 846
2025
Q3
$13K Buy
777
+694
+836% +$10.4K ﹤0.01% 889
2025
Q2
$1K Hold
83
– – ﹤0.01% 1366
2025
Q1
$1K Sell
83
-53,634
-100% -$762K ﹤0.01% 1388
2024
Q4
$705K Buy
53,717
+5,712
+12% +$78.9K 0.03% 502
2024
Q3
$556K Sell
48,005
-6,475
-12% -$61.1K 0.02% 552
2024
Q2
$411K Buy
54,480
+17,678
+48% +$146K 0.03% 562
2024
Q1
$369K Buy
+36,802
New +$342K 0.05% 474

Other funds holding MD

Harbor Capital Advisors's MD Position: Q1 2026 in Review

Harbor Capital Advisors sold out of Pediatrix Medical (MD) in Q1 2026, closing a stake of 764 shares — an estimated $16K sold.

Harbor Capital Advisors first reported a position in MD in Q1 2024 and held it in 8 quarters. The position peaked at $705K in Q4 2024. 297 funds tracked by Wall St. Rank hold MD as of Q1 2026.

  • Harbor Capital Advisors reported no remaining Pediatrix Medical position as of Q1 2026 after selling out during the quarter.
  • Harbor Capital Advisors sold 764 Pediatrix Medical shares in Q1 2026, an estimated $16K.
  • Harbor Capital Advisors first reported a position in Pediatrix Medical in Q1 2024 and held it in 8 quarters.
  • Harbor Capital Advisors's Pediatrix Medical position peaked at $705K in Q4 2024.
  • 297 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2026.

Based on Harbor Capital Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.